A detailed history of Nantahala Capital Management, LLC transactions in Eagle Pharmaceuticals, Inc. stock. As of the latest transaction made, Nantahala Capital Management, LLC holds 1,962,070 shares of EGRX stock, worth $784,828. This represents 0.73% of its overall portfolio holdings.

Number of Shares
1,962,070
Previous 1,962,070 -0.0%
Holding current value
$784,828
Previous $11 Million -0.0%
% of portfolio
0.73%
Previous 0.74%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$3.34 - $5.6 $2.35 Million - $3.94 Million
703,308 Added 55.87%
1,962,070 $11 Million
Q1 2024

May 15, 2024

BUY
$4.26 - $6.51 $5.36 Million - $8.19 Million
1,258,762 New
1,258,762 $6.6 Million

Others Institutions Holding EGRX

About EAGLE PHARMACEUTICALS, INC.


  • Ticker EGRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 13,015,900
  • Market Cap $5.21M
  • Description
  • Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...
More about EGRX
Track This Portfolio

Track Nantahala Capital Management, LLC Portfolio

Follow Nantahala Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nantahala Capital Management, LLC with notifications on news.